Leukemia Cancer Market Report

China Leukemia Cancer Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：169
  • REPORT CODE：GMM1758161
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Leukemia Cancer industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Spectrum Pharmaceuticals

    • Takeda Oncology

    • Roche

    • Teva Pharmaceutical

    • Sunesis Pharmaceuticals

    • Pfizer

    • Novartis

    • EISAI

    • GSK

    • Daiichi Sankyo

    • Bristol-Myers Squibb

    By Type:

    • Acute Myeloid Leukaemia (AML)

    • Chronic Myeloid Leukaemia (CML)

    • Chronic Lymphocytic Leukaemia (CLL)

    • Acute Lymphoblastic Leukaemia (ALL)

    By Application:

    • Targeted Therapy

    • Stem Cell Transplant

    • Radiation Therapy

    • Biological Therapy

    • Chemotherapy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Leukemia Cancer Market Overview 2018-2029

    • 1.1 China Leukemia Cancer Industry Development Overview

    • 1.2 China Leukemia Cancer Industry Development History

    • 1.3 China Leukemia Cancer Industry Market Size (2018-2029)

    • 1.4 China Leukemia Cancer Market Analysis by Type from Production Side

      • 1.4.1 China Leukemia Cancer Production Volume, Production Value and Growth Rate of Acute Myeloid Leukaemia (AML) (2018-2029)

      • 1.4.2 China Leukemia Cancer Production Volume, Production Value and Growth Rate of Chronic Myeloid Leukaemia (CML) (2018-2029)

      • 1.4.3 China Leukemia Cancer Production Volume, Production Value and Growth Rate of Chronic Lymphocytic Leukaemia (CLL) (2018-2029)

      • 1.4.4 China Leukemia Cancer Production Volume, Production Value and Growth Rate of Acute Lymphoblastic Leukaemia (ALL) (2018-2029)

    • 1.5 China Leukemia Cancer Market Analysis by Application from Consumption End

      • 1.5.1 China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)

      • 1.5.2 China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Stem Cell Transplant (2018-2029)

      • 1.5.3 China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Radiation Therapy (2018-2029)

      • 1.5.4 China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Biological Therapy (2018-2029)

      • 1.5.5 China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

    • 1.6 China Leukemia Cancer Market Analysis by Region

      • 1.6.1 North China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Leukemia Cancer Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    Chapter 2 China Leukemia Cancer Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Leukemia Cancer Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Leukemia Cancer Market Status and Competition Analysis in 2023

      • 2.2.3 China Leukemia Cancer Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Leukemia Cancer Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Leukemia Cancer Industry Development

    Chapter 3 Leukemia CancerIndustry Chain Analysis

    • 3.1 Leukemia Cancer Industry Chain

    • 3.2 Leukemia Cancer Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Leukemia Cancer Market

    • 3.3 Leukemia Cancer Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Leukemia Cancer Market

    Chapter 4 China Leukemia Cancer Market, by Type

    • 4.1 China Leukemia Cancer Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Leukemia Cancer Total Production Volume and Growth Rate from Production Side

    • 4.5 China Leukemia Cancer Production Volume and Growth Rate, by Type

      • 4.5.1 China Leukemia Cancer Production Volume and Growth Rate of Acute Myeloid Leukaemia (AML)

      • 4.5.2 China Leukemia Cancer Production Volume and Growth Rate of Chronic Myeloid Leukaemia (CML)

      • 4.5.3 China Leukemia Cancer Production Volume and Growth Rate of Chronic Lymphocytic Leukaemia (CLL)

      • 4.5.4 China Leukemia Cancer Production Volume and Growth Rate of Acute Lymphoblastic Leukaemia (ALL)

    Chapter 5 China Leukemia Cancer Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Leukemia Cancer Total Market Size and Growth Rate from Consumption End

    • 5.5 China Leukemia Cancer Market Size and Growth Rate, by Application

      • 5.5.1 China Leukemia Cancer Market Size and Growth Rate of Targeted Therapy

      • 5.5.2 China Leukemia Cancer Market Size and Growth Rate of Stem Cell Transplant

      • 5.5.3 China Leukemia Cancer Market Size and Growth Rate of Radiation Therapy

      • 5.5.4 China Leukemia Cancer Market Size and Growth Rate of Biological Therapy

      • 5.5.5 China Leukemia Cancer Market Size and Growth Rate of Chemotherapy

    Chapter 6 China Leukemia Cancer Market, by Region

    • 6.1 China Leukemia Cancer Production Volume and Production Value, by Region

    • 6.2 China Leukemia Cancer Sales Volume and Sales Value, by Region

    Chapter 7 North China Leukemia Cancer Market Analysis

    • 7.1 North China Leukemia Cancer Market, by Type

    • 7.2 North China Leukemia Cancer Market, by Application

    Chapter 8 Central China Leukemia Cancer Market Analysis

    • 8.1 Central China Leukemia Cancer Market, by Type

    • 8.2 Central China Leukemia Cancer Market, by Application

    Chapter 9 South China Leukemia Cancer Market Analysis

    • 9.1 South China Leukemia Cancer Market, by Type

    • 9.2 South China Leukemia Cancer Market, by Application

    Chapter 10 East China Leukemia Cancer Market Analysis

    • 10.1 East China Leukemia Cancer Market, by Type

    • 10.2 East China Leukemia Cancer Market, by Application

    Chapter 11 Northeast China Leukemia Cancer Market Analysis

    • 11.1 Northeast China Leukemia Cancer Market, by Type

    • 11.2 Northeast China Leukemia Cancer Market, by Application

    Chapter 12 Southwest China Leukemia Cancer Market Analysis

    • 12.1 Southwest China Leukemia Cancer Market, by Type

    • 12.2 Southwest China Leukemia Cancer Market, by Application

    Chapter 13 Northwest China Leukemia Cancer Market Analysis

    • 13.1 Northwest China Leukemia Cancer Market, by Type

    • 13.2 Northwest China Leukemia Cancer Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Spectrum Pharmaceuticals

        • 14.1.1 Spectrum Pharmaceuticals Company Profile

        • 14.1.2 Spectrum Pharmaceuticals Leukemia Cancer Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Takeda Oncology

        • 14.2.1 Takeda Oncology Company Profile

        • 14.2.2 Takeda Oncology Leukemia Cancer Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Roche

        • 14.3.1 Roche Company Profile

        • 14.3.2 Roche Leukemia Cancer Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Teva Pharmaceutical

        • 14.4.1 Teva Pharmaceutical Company Profile

        • 14.4.2 Teva Pharmaceutical Leukemia Cancer Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sunesis Pharmaceuticals

        • 14.5.1 Sunesis Pharmaceuticals Company Profile

        • 14.5.2 Sunesis Pharmaceuticals Leukemia Cancer Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer

        • 14.6.1 Pfizer Company Profile

        • 14.6.2 Pfizer Leukemia Cancer Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis

        • 14.7.1 Novartis Company Profile

        • 14.7.2 Novartis Leukemia Cancer Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 EISAI

        • 14.8.1 EISAI Company Profile

        • 14.8.2 EISAI Leukemia Cancer Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GSK

        • 14.9.1 GSK Company Profile

        • 14.9.2 GSK Leukemia Cancer Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Daiichi Sankyo

        • 14.10.1 Daiichi Sankyo Company Profile

        • 14.10.2 Daiichi Sankyo Leukemia Cancer Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Bristol-Myers Squibb

        • 14.11.1 Bristol-Myers Squibb Company Profile

        • 14.11.2 Bristol-Myers Squibb Leukemia Cancer Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Leukemia Cancer Industry Research Conclusions

    • 15.2 Leukemia Cancer Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Leukemia Cancer Industry Market Size (2018-2029)

    • Figure China Leukemia Cancer Production Volume, Production Value and Growth Rate of Acute Myeloid Leukaemia (AML) (2018-2029)

    • Figure China Leukemia Cancer Production Volume, Production Value and Growth Rate of Chronic Myeloid Leukaemia (CML) (2018-2029)

    • Figure China Leukemia Cancer Production Volume, Production Value and Growth Rate of Chronic Lymphocytic Leukaemia (CLL) (2018-2029)

    • Figure China Leukemia Cancer Production Volume, Production Value and Growth Rate of Acute Lymphoblastic Leukaemia (ALL) (2018-2029)

    • Figure China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Targeted Therapy (2018-2029)

    • Figure China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Stem Cell Transplant (2018-2029)

    • Figure China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Radiation Therapy (2018-2029)

    • Figure China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Biological Therapy (2018-2029)

    • Figure China Leukemia Cancer Sales Volume, Sales Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure North China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure Central China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure South China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure East China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Leukemia Cancer Market Size and Growth Rate from 2018-2029

    • Figure Leukemia Cancer Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Leukemia Cancer Market Share by Type in 2018

    • Figure China Leukemia Cancer Market Share by Type in 2023

    • Figure China Leukemia Cancer Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Leukemia Cancer Production Volume and Growth Rate of Acute Myeloid Leukaemia (AML) (2018-2023)

    • Figure China Leukemia Cancer Production Volume and Growth Rate of Chronic Myeloid Leukaemia (CML) (2018-2023)

    • Figure China Leukemia Cancer Production Volume and Growth Rate of Chronic Lymphocytic Leukaemia (CLL) (2018-2023)

    • Figure China Leukemia Cancer Production Volume and Growth Rate of Acute Lymphoblastic Leukaemia (ALL) (2018-2023)

    • Figure China Leukemia Cancer Market Share by Application in 2018

    • Figure China Leukemia Cancer Market Share by Application in 2023

    • Figure China Leukemia Cancer Total Market Size and Growth Rate from Consumption End

    • Figure China Leukemia Cancer Market Size and Growth Rate of Targeted Therapy (2018-2023)

    • Figure China Leukemia Cancer Market Size and Growth Rate of Stem Cell Transplant (2018-2023)

    • Figure China Leukemia Cancer Market Size and Growth Rate of Radiation Therapy (2018-2023)

    • Figure China Leukemia Cancer Market Size and Growth Rate of Biological Therapy (2018-2023)

    • Figure China Leukemia Cancer Market Size and Growth Rate of Chemotherapy (2018-2023)

    • Table China Leukemia Cancer Production Volume by Region (2018-2023)

    • Table China Leukemia Cancer Production Volume Share by Region (2018-2023)

    • Figure China Leukemia Cancer Production Volume Share by Region (2018-2023)

    • Table China Leukemia Cancer Production Value by Region (2018-2023)

    • Table China Leukemia Cancer Production Value Share by Region (2018-2023)

    • Figure China Leukemia Cancer Production Value Share by Region (2018-2023)

    • Table China Leukemia Cancer Sales Volume by Region (2018-2023)

    • Table China Leukemia Cancer Sales Volume Share by Region (2018-2023)

    • Figure China Leukemia Cancer Sales Volume Share by Region (2018-2023)

    • Table China Leukemia Cancer Sales Value by Region (2018-2023)

    • Table China Leukemia Cancer Sales Value Share by Region (2018-2023)

    • Figure China Leukemia Cancer Sales Value Share by Region (2018-2023)

    • Table North China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table North China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure North China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table North China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table North China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure North China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table Central China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table Central China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure Central China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table Central China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table Central China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure Central China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table South China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table South China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure South China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table South China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table South China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure South China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table East China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table East China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure East China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table East China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table East China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure East China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table Northeast China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table Northeast China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure Northeast China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table Northeast China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table Northeast China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table Southwest China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table Southwest China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure Southwest China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table Southwest China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table Southwest China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table Northwest China Leukemia Cancer Production Volume by Type (2018-2023)

    • Table Northwest China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Figure Northwest China Leukemia Cancer Production Volume Share by Type (2018-2023)

    • Table Northwest China Leukemia Cancer Sales Volume by Application (2018-2023)

    • Table Northwest China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Leukemia Cancer Sales Volume Share by Application (2018-2023)

    • Table Spectrum Pharmaceuticals Company Profile

    • Table Spectrum Pharmaceuticals Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Takeda Oncology Company Profile

    • Table Takeda Oncology Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Sunesis Pharmaceuticals Company Profile

    • Table Sunesis Pharmaceuticals Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table EISAI Company Profile

    • Table EISAI Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table GSK Company Profile

    • Table GSK Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Profile

    • Table Daiichi Sankyo Leukemia Cancer Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Leukemia Cancer Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US